GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (NAS:AMPH) » Definitions » E10

AMPH (Amphastar Pharmaceuticals) E10 : $1.05 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Amphastar Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Amphastar Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was $0.740. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.05 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Amphastar Pharmaceuticals's average E10 Growth Rate was 52.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-14), Amphastar Pharmaceuticals's current stock price is $26.24. Amphastar Pharmaceuticals's E10 for the quarter that ended in Dec. 2024 was $1.05. Amphastar Pharmaceuticals's Shiller PE Ratio of today is 24.99.

During the past 13 years, the highest Shiller PE Ratio of Amphastar Pharmaceuticals was 114.20. The lowest was 14.35. And the median was 53.67.


Amphastar Pharmaceuticals E10 Historical Data

The historical data trend for Amphastar Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals E10 Chart

Amphastar Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.60 0.69 1.05

Amphastar Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.79 0.87 0.96 1.05

Competitive Comparison of Amphastar Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amphastar Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Shiller PE Ratio falls into.



Amphastar Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amphastar Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.74/133.1571*133.1571
=0.740

Current CPI (Dec. 2024) = 133.1571.

Amphastar Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201503 -0.010 99.621 -0.013
201506 -0.150 100.684 -0.198
201509 -0.070 100.392 -0.093
201512 0.170 99.792 0.227
201603 0.050 100.470 0.066
201606 0.150 101.688 0.196
201609 0.080 101.861 0.105
201612 -0.060 101.863 -0.078
201703 0.020 102.862 0.026
201706 0.040 103.349 0.052
201709 0.002 104.136 0.003
201712 0.030 104.011 0.038
201803 -0.150 105.290 -0.190
201806 -0.060 106.317 -0.075
201809 0.050 106.507 0.063
201812 0.040 105.998 0.050
201903 0.020 107.251 0.025
201906 0.960 108.070 1.183
201909 0.030 108.329 0.037
201912 -0.020 108.420 -0.025
202003 0.080 108.902 0.098
202006 -0.004 108.767 -0.005
202009 0.080 109.815 0.097
202012 -0.130 109.897 -0.158
202103 0.100 111.754 0.119
202106 0.160 114.631 0.186
202109 0.590 115.734 0.679
202112 0.390 117.630 0.441
202203 0.470 121.301 0.516
202206 0.330 125.017 0.351
202209 0.300 125.227 0.319
202212 0.660 125.222 0.702
202303 0.500 127.348 0.523
202306 0.490 128.729 0.507
202309 0.910 129.860 0.933
202312 0.680 129.419 0.700
202403 0.810 131.776 0.818
202406 0.730 132.554 0.733
202409 0.780 133.029 0.781
202412 0.740 133.157 0.740

Add all the adjusted EPS together and divide 10 will get our e10.


Amphastar Pharmaceuticals  (NAS:AMPH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amphastar Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26.24/1.05
=24.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Amphastar Pharmaceuticals was 114.20. The lowest was 14.35. And the median was 53.67.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Amphastar Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Amphastar Pharmaceuticals Business Description

Traded in Other Exchanges
Address
11570 6th Street, Rancho Cucamonga, CA, USA, 91730
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Executives
Rong Zhou officer: EVP, Production C/O AMPHASTAR PHARMACEUTICALS INC., 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Richard K Prins director
William J Peters officer: CFO, SVP & Treasurer C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Yakob Liawatidewi officer: SVP Corp Admin Center C/O AMPHASTAR PHARMACEUTICALS INC, 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730
Floyd F. Petersen director 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Michael A Zasloff director
Mary Z. Luo director, 10 percent owner, officer: COO and Chief Scientist 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Gayle Deflin director 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Diane G. Gerst officer: EVP, QA & Regulatory Affairs 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Howard Lee director 13F-2, NO. 36, LANE 48, SECTION 3, NAN-JING EAST ROAD, TAIPEI, TAIWAN F4 00000
Jack Y. Zhang director, 10 percent owner, officer: CEO & Chief Scientific Officer 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
David Maris director C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Richard Koo director 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Jason B. Shandell director, officer: President 11570 6TH STREET, RANCHO CUCAMONGA CA 91730
Applied Physics & Chemistry Laboratories, Inc. 10 percent owner 13760 MAGNOLIA AVENUE, CHINO CA 91710